In 2007 Lyrica became the first FDA-approved treatment to help relieve the chronic, widespread muscle pain of fibromyalgia. Fibromyalgia is a medical condition with symptoms that often include muscle tenderness, morning stiffness and fatigue. The pain from fibromyalgia is one of the most common types of chronic widespread pain in the U.S., affecting more than 5 million people. It may vary from mild to severe, and can have a devastating effect on people, affecting their ability to work and engage in everyday activities, and placing stress on family and other personal relationships. Studies show that Lyrica provides significant pain relief in as early as one week for some patients.